1. Home
  2. RMBI vs CRDL Comparison

RMBI vs CRDL Comparison

Compare RMBI & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMBI
  • CRDL
  • Stock Information
  • Founded
  • RMBI 1887
  • CRDL 2017
  • Country
  • RMBI United States
  • CRDL Canada
  • Employees
  • RMBI N/A
  • CRDL N/A
  • Industry
  • RMBI Major Banks
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RMBI Finance
  • CRDL Health Care
  • Exchange
  • RMBI Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • RMBI 125.7M
  • CRDL 102.0M
  • IPO Year
  • RMBI 2019
  • CRDL N/A
  • Fundamental
  • Price
  • RMBI $13.84
  • CRDL $1.08
  • Analyst Decision
  • RMBI
  • CRDL Strong Buy
  • Analyst Count
  • RMBI 0
  • CRDL 3
  • Target Price
  • RMBI N/A
  • CRDL $9.00
  • AVG Volume (30 Days)
  • RMBI 29.4K
  • CRDL 223.0K
  • Earning Date
  • RMBI 04-28-2025
  • CRDL 05-13-2025
  • Dividend Yield
  • RMBI 4.33%
  • CRDL N/A
  • EPS Growth
  • RMBI 1.10
  • CRDL N/A
  • EPS
  • RMBI 0.92
  • CRDL N/A
  • Revenue
  • RMBI $42,915,048.00
  • CRDL N/A
  • Revenue This Year
  • RMBI N/A
  • CRDL N/A
  • Revenue Next Year
  • RMBI N/A
  • CRDL N/A
  • P/E Ratio
  • RMBI $14.93
  • CRDL N/A
  • Revenue Growth
  • RMBI 2.81
  • CRDL N/A
  • 52 Week Low
  • RMBI $10.15
  • CRDL $0.77
  • 52 Week High
  • RMBI $15.15
  • CRDL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • RMBI 68.11
  • CRDL 55.91
  • Support Level
  • RMBI $11.98
  • CRDL $0.92
  • Resistance Level
  • RMBI $12.80
  • CRDL $1.08
  • Average True Range (ATR)
  • RMBI 0.56
  • CRDL 0.11
  • MACD
  • RMBI 0.19
  • CRDL 0.02
  • Stochastic Oscillator
  • RMBI 88.70
  • CRDL 93.92

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: